Stocks · Korea
003060
KOSPI
Aprogen Biologics
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+2.12%
1M-10.83%
3M-26.84%
6M+432.87%
1Y+146.79%
YTD+186.78%
52W high6,370원
52W low—
From 52W high-75.82%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 652억 | -54억 | 56억 | -8.3% |
| 2023 | 874억 | -575억 | -1,153억 | -65.8% |
| 2024 | 674억 | -528억 | -1,050억 | -78.4% |
| 2025 | 732억 | -604억 | -1,683억 | -82.4% |
| Quarterly | ||||
| 2024 4Q | 220억 | -160억 | -600억 | -72.7% |
| 2025 1Q | 168억 | -157억 | -431억 | -93.4% |
| 2025 2Q | 149억 | -180억 | -669억 | -120.5% |
| 2025 3Q | 211억 | -107억 | -245억 | -50.5% |
| 2025 4Q | 204억 | -160억 | -338억 | -78.5% |
| 2026 1Q | 216억 | -136억 | -46억 | -63.0% |
Company
Address: 서울특별시 송파구 백제고분로 480 4층 (방이동, 풍문빌딩)
Peers in the same sector
Recent filings
- 2026-09-23[기재정정]주요사항보고서(유상증자결정) Major
- 2026-09-11[기재정정]주요사항보고서(유상증자결정) Major
- 2026-09-03주요사항보고서(유상증자결정) Major
- 2026-08-13반기보고서 (2026.06)
- 2026-07-14주요사항보고서(유상증자결정) Major
- 2026-06-29[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-06-24[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-06-19[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-06-02[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-05-26주요사항보고서(전환사채권발행결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-04-13에이프로젠바이오로직스, 20억 규모 제3자 배정 유상증자 블로터
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.